ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
The University of Texas MD Anderson Cancer Center at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
The University of Texas MD Anderson Cancer Center brings 4 presentations to ACR Convergence 2026 in Orlando. Its program centres on rheumatic complications of cancer immunotherapy, including checkpoint inhibitor arthritis and Raynaud's phenomenon, with work on point-of-care ultrasound and air pollution in systemic sclerosis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
A cancer treatment and research center affiliated with The University of Texas System. | Talk Sat Nov 7 10:00am–10:30am Lecture B10: Curbside to Clinic: Point-of-Care Ultrasound for Real-Time Rheumatology Decisions Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm |
Find decision makers at The University of Texas MD Anderson Cancer Center
Tell us what you sell and we’ll find the people at The University of Texas MD Anderson Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction